These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14870501)

  • 1. [What to use to treat osteoporosis?].
    Välimäki MJ
    Duodecim; 2003; 119(24):2409-12. PubMed ID: 14870501
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant parathyroid hormone in the management of osteoporosis.
    Compston J
    Calcif Tissue Int; 2005 Aug; 77(2):65-71. PubMed ID: 16059774
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of osteoporosis in men.
    Orwoll ES
    Calcif Tissue Int; 2004 Aug; 75(2):114-9. PubMed ID: 15383924
    [No Abstract]   [Full Text] [Related]  

  • 4. [News on osteoporosis: good effect of treatment with diphosphonates].
    Lakartidningen; 1997 Feb; 94(8):653-5. PubMed ID: 9072657
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is reliable in therapy of osteoporosis?].
    Ziegler R
    Internist (Berl); 1990 Nov; 31(11):680-8. PubMed ID: 2289853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of progression of decreasing bone mass and manifest osteoporosis].
    Ringe JD
    Internist (Berl); 1993 Apr; 34(4):300-6. PubMed ID: 8486473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Who are the candidates for the treatment by raloxifen ?].
    Hagino H
    Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathyroid hormone for osteroporsis: why and who to treat?].
    Ferrari S; Rizzoli R
    Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modern treatment of primary osteoporosis].
    Bottermann P
    Internist (Berl); 1994 Dec; 35(12):1105-16. PubMed ID: 7883514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New therapy for severe osteoporosis. Bone development with parathyroid hormone? (interview by Brigitte Moreano)].
    Ringe JD
    MMW Fortschr Med; 2001 May; 143(22):10. PubMed ID: 11460391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Androgens and bone metabolism. Significance in osteoporosis in man and woman].
    Kasperk CH; Ziegler R
    Dtsch Med Wochenschr; 1992 Jun; 117(25):990-6. PubMed ID: 1611969
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.
    Tashjian AH; Chabner BA
    J Bone Miner Res; 2002 Jul; 17(7):1151-61. PubMed ID: 12096828
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the management of postmenopausal osteoporosis for GPs.
    O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
    Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primate models of osteoporosis.
    Jerome CP
    Lab Anim Sci; 1998 Dec; 48(6):618-22. PubMed ID: 10090086
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of estrogen on bone-turnover and its prevention and control of osteoporosis ].
    Lin SQ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):728-9. PubMed ID: 15949374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 20. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.